dsm-firmenich Ventures
Heerlen, NetherlandsFounded 2001
dsm-firmenich Ventures is the corporate venture capital arm of dsm-firmenich, a global leader in nutrition, health, and beauty. It invests in early-stage startups across perfumery & beauty, taste, texture & health, and health, nutrition & care.
They made 3 investments in the last 12 months. Their most common stage is series-a (43% of deals). Average disclosed round size is $11.1M (across 10 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PP2 Science, Inc. | Unknown | $23M | May 2026 |
 ATRO Medical | Unknown | — | Feb 2026 |
| OOctarine bio | Series A | — | Jan 2026 |
| OOctarine bio | Unknown | $4.7M | Nov 2023 |
| MMeatable | Growth | $35M | Aug 2023 |
 Paleo | Series A | $12.7M | Feb 2023 |
| MMEALA | Pre-Seed | $1.9M | Feb 2023 |
 Chinova Bioworks | Series A | $6M | Jun 2022 |
| OOK Capsule | Seed | $9.5M | Mar 2022 |
| AAnimalBiome | Series A | $8.6M | Jan 2021 |
| LLeading Edge Equipment | Series A | $7.6M | Oct 2020 |
 Atro | Unknown | — | — |
| AAnimalBiome | Seed | $1.5M | — |
| EExoLab | Series A | — | — |
Top Co-Investors
Unconventional Ventures2 shared
Kae Capital2 shared
The Footprint Firm2 shared
Business Angel1 shared
Edaphon1 shared
Rich Products Ventures1 shared
Rhapsody Venture Partners1 shared
Invest-NL1 shared
BlueYard Capital1 shared
Agronomics1 shared
Prime Impact Fund1 shared
Clean Energy Ventures1 shared
Next Capital1 shared
Mucker Capital1 shared
SFPIM1 shared
Planet A1 shared
Beyond Impact1 shared
Siddhi Capital1 shared
Gimv1 shared
CHANEL1 shared
Last updated: 8 September 2026